Agents and Actions

, Volume 10, Issue 6, pp 566–569 | Cite as

Cyclic nucleotides in rheumatoid arthritis

  • Ludvig E. Trang
  • Olle Lövgren
  • Robert Horn
  • Otto Walaas
  • Oled Mjös
Histamine and Kinins Immunosuppression and Inflammation Cyclic Nucleotides and Cellular Secretion
  • 18 Downloads

Abstract

Cyclic 3′,5′-adenosine monophosphate (cAMP) and cyclic 3′,5′-guanosine monophosphate (cGMP) may influence important regulatory mechanisms in the rheumatoid inflammatory process. It has been claimed that fasting imporves the condition of the patient with rheumatoid arthritis (RA). The present study was designed to measure cAMP in plasma and urine and cGMP in urine in medically untreated RA patients. 12 female patients were investigated in a cross-over study during a control and a fasting period. They received no other drugs than analgesics during these periods.

Levels of plasma and urinary cAMP found during the control period were somewhat lower than previously reported. However, the ratio cAMP/cGMP in urine was 10 to 1 which is reported to be normal. Clinical and laboratory variables of inflammatory activity were significantly improved during the 7-day fasting period. The ratio of cAMP/cGMP in urine was significantly increased on days 2–4 and coincided in time with the maximum of clinical improvement. Cyclic AMP concentrations were lowered both in plasma and urine during fasting. This is in contrast to fasting in normal and obese subjects reported in previous studies.

Keywords

Rheumatoid Arthritis Rheumatoid Arthritis Patient Monophosphate Guanosine Obese Subject 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    F.R. De Rubertis, T.V. Zenser, W.H. Adler andT. Hudson,Role of Cyclic Adenosine 3′,5′-Monophosphate in Lymphocyte Mitogenesis, J. Immun.113, 151–161 (1974).PubMedGoogle Scholar
  2. [2]
    T.B. Strom, M.S. Hirsch, P.H. Black, C.B. Carpenter, S.M. Phillips andJ.P. Merill,Modulation of GvH Proliferation by Cyclic Nucleotides. Transplant. Proc.7, Suppl. 1, 305–307 (1975).Google Scholar
  3. [3]
    C.S. Henney, H.R. Bourne andL.M. Lichtenstein,The Role of Cyclic 3′,5′-Adenosine Monophosphate in the Specific Cytolytic Activity of Lymphocytes, J. Immun.108, 1526–1534 (1972).PubMedGoogle Scholar
  4. [4]
    K.L. Melmon, Y. Weinstein, G.M. Shearer, H.R. Bourne andS. Bauminger,Separation of Specific Antibody-forming Mouse Cells by their Adherence to Insolubilized Endogenous Hormones, J. clin. Invest.53, 22–30 (1974).PubMedGoogle Scholar
  5. [5]
    I. Rivkin, J. Rosenblatt andE.L. Becker,The Role of Cyclic AMP in the Chemotactic Responsiveness and Spontaneous Motility of Rabbit Peritoneal Neurophils, J. Immun.115, 1126–1134 (1975).PubMedGoogle Scholar
  6. [6]
    C.J. Ignarro,Regulation of Lysosomal Enzyme Secretion: Role in Inflammation, Agents and Actions4, 241–258 (1974).CrossRefPubMedGoogle Scholar
  7. [7]
    I.L. Bonta, M.J. Parnham, M.J.P. Adolfs andL. Van Vliet,Dual Function of E-Type Prostaglandins in Models of Chronic Inflammation, in:Perspectives in Inflammation (Eds. D.A. Willoughby, J.P. Giroud and G.P. Velo; MTP Press, Lancaster 1977), pp. 265–275.Google Scholar
  8. [8]
    L.E. Trang, O. Lövgren, A.E. Roch-Norlund, R.S. Horn andO. Walaas,Cyclic Nucleotides in Joint Fluid in rheumatoid Arthritis and in Reiter's Syndrome, Scand. J. Rheumatol.8, 91–96 (1979).PubMedGoogle Scholar
  9. [9]
    M.W. Ropes, G.A. Bennett, S. Cobb, R. Jacox andR.A. Jessar,1958 Revision of Diagnostic Criteria for Rheumatoid Arthritis, Bull. Rheum. Dis.9, 175–176 (1958).PubMedGoogle Scholar
  10. [10]
    D.M. Ritchie, J.A. Boyle, J.M. McInnes, M.K. Jasani, T.G. Dalakos, P. Grieveson andW.W. Buchanan,Clinical Studies with an Articular Index for the Assessment of Joint Tenderness in Patients with Rheumatoid Arthritis, Q. J. Med.37, 393–406 (1968).PubMedGoogle Scholar
  11. [11]
    A.E. Roch-Norland, R.S. Horn, K.M. Gautvik, E. Walaas andO. Walaas,Effect of Epinephrine and Insulin on Adenosine 3′,5′ Cyclic Monophosphate Dependent Protein Kinase in Human Skeletal Muscle in vivo, Hormone Metabolic Res.10, 208–213 (1978).Google Scholar
  12. [12]
    S. Wadskov, R. Donde andJ. Sylvest,Plasma and Synovial Fluid cAMP in Patients with Rheumatoid Arthritis, Scand. J. Rheumatol.8, 136–138 (1979).PubMedGoogle Scholar
  13. [13]
    R.I. Ryms andS. Thanbi,Synovial Fluid and Plasma Cyclic Nucleotide Levels in Patients with Arthritis, Arthritis Rheum.22, 654 (1979).Google Scholar
  14. [14]
    R.H. Williams, J. Barish andJ.W. Ensinck,Hormone Effects upon Cyclic Nucleotide Excretion in Man, Proc. Soc. exp. Biol. N.Y.139, 447–454 (1972).Google Scholar
  15. [15]
    B.P. Turpin, M.W. Austin andS. S. Solomon,Urinary and Plasma Cyclic AMP Levels during Short Term Starvation in Obese Man. Response to Glucagon Stimulation, Horm. Metab. Res.10, 36–37 (1978).PubMedGoogle Scholar
  16. [16]
    O.D. Mjös, H. Wik-Mo, T. Henden andH. Wang,Increased Plasma Cyclic AMP Concentration in Fasting Man, Scand. J. clin. lab. Invest.37, 439–442 (1977).PubMedGoogle Scholar

Copyright information

© Birkhäuser-Verlag 1980

Authors and Affiliations

  • Ludvig E. Trang
    • 1
  • Olle Lövgren
    • 1
  • Robert Horn
    • 2
  • Otto Walaas
    • 2
  • Oled Mjös
    • 3
  1. 1.Rheumatological and Metabolic Research LaboratorySt Eriks HospitalStockholmSweden
  2. 2.Institute of Medical BiochemistryUniversity of OsloNorway
  3. 3.Institute of Medical BiologyUniversity of TromsöNorway

Personalised recommendations